Northfield Labs files for bankruptcy protection
This article was originally published in Scrip
Executive Summary
Northfield Laboratories has filed for bankruptcy protection after its red blood cell substitute PolyHeme was denied approval by the US FDA. The US firm said it will liquidate its assets in a chapter 11 bankruptcy filing.